Evolus, Inc. – Trademark Portfolio
Entity Type: 03
Evolus, Inc. owns a portfolio of 28 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as EE, EVOLUS, EVOLUX, JEUVEAU, and EVOLYSSE. Of these, 7 are registered and 14 are pending. The portfolio spans 4 Nice Classification classes, led by Class 5 (Pharmaceuticals) and Class 44 (Medical Services). Headquartered in Newport Beach, CA.
520 Newport Center Dr., Suite 1200
Newport Beach, CA 92660
Showing of trademarks Trademarks
Trademark Classifications
Evolus, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Evolus, Inc. have?
Evolus, Inc. has 28 U.S. trademarks filed with the USPTO. Of these, 7 registered, 14 pending, 7 abandoned.
What trademark classes does Evolus, Inc. file in?
Evolus, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 35 (Advertising & Business), Class 41 (Education & Entertainment). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Evolus, Inc.'s most well-known trademarks?
Evolus, Inc.'s registered trademark portfolio includes well-known marks such as EE, EVOLUS, EVOLUX, JEUVEAU, and EVOLYSSE. These are among 7 currently registered trademarks in the portfolio.
What is Evolus, Inc.'s trademark registration success rate?
Evolus, Inc. has a 50% trademark registration rate, with 7 out of 14 resolved applications resulting in successful registration. Currently, 14 applications are pending review.